S&T Lead A Healthy Life
In Global, For Global
  • Mutual Respect
  • Mutual Motivation
  • Mutual Success

About Us

  The Queen's Ark was established with the original intention of being committed to accelerating scientific innovation through a brand-new operation model to benefit patients, which is the top priority of all our work. We possess strong commercial transformation capabilities and, together with our partners, address a series of medical challenges faced at different stages of product development and for various disease types. ...

Product Pipeline

The Road to Fighting Cancer: Igniting the Light of Hope for Life

Research

The Road to Fighting Cancer: Igniting the Light of Hope for Life

In the long journey of life, cancer is like a fierce monster that constantly threatens human health and happiness. However, on this challenging battlefield, there is a group of fearless warriors who, with firm beliefs and burning dreams, are dedicated to the research and exploration of the anti-cancer cause. They are us - a team focusing on the research and development of anti-cancer drugs.
  • 53 Core patents
  • 45 Invention Patent
  • 8 Utility model patent
  • Antibody drugs&ADC

  • Cell therapies

  • Gene therapies

  • Cancer vaccines

  • Small molecules

Technology Platform

Gathering Global Wisdom, Forging an Anti-Cancer Legend

In the vast starry sky of life, cancer is like a series of dark meteors, threatening the bright light of countless lives. However, there is such a group of brave light chasers - the employees and collaborators of Queen's Ark Pharmaceuticals. With a burning dream and the mission of "pooling global resources to develop innovative drugs for the world", they have embarked on a magnificent journey against cancer.

Cooperation

Investment-driven Model to Lead the Future of the Pharmaceutical Industry

In today's highly competitive pharmaceutical field, Queen's Ark Pharmaceuticals is like a brilliant new star. With its unique investment-driven model and novel operation concept, it has risen rapidly and attracted the attention of numerous investment institutions.